Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Denisk, never heard of such a thing. Why is the email address from the EU? What kind of organization are you referring to?
Has anyone noticed a change in the way AMRN daily closing quote is being sent from a different IP address? It's from a foreign email address see below. I wonder what this is all about.
Amarin Corporation Plc C/O Amarin Pharma, Inc. <no-reply@notification.gcs-web.com>
STOCK QUOTE NOTIFICATION FROM AMARIN
Company: Amarin Corporation Plc C/O Amarin Pharma, Inc.
Ticker: AMRN
Exchange: NASDAQ
Last Trade: $1.12
Change: -0.04
% Change: -3.45%
Volume: 1,209,699
Day's High: $1.17
Day's Low: $1.11
Previous Close: $1.16
Please do not reply to this email. The sender address is not an active mailbox. Incoming email messages are automatically deleted.
If you have any questions about the processing and storage location of your personal data, or if you wish to send us comments or additional information, please contact us at privacy@amarincorp.eu
© 2023 Amarin Pharmaceuticals Ireland Limited. AMARIN, VASCEPA, VAZKEPA and REDUCE-IT are registered trademarks of Amarin Pharmaceuticals Ireland Limited in the United States, European Union, United Kingdom, and other countries and regions.
Legal Information
Amarin Pharmaceuticals Ireland Limited
Registered address: 88 Harcourt Street, Dublin 2
Company number: 408912
Privacy Policy | Unsubscribe
agordon, thx for link. Over 500 pages I did see where the revs from the Hannan district were approx. $2.3 mill. Nice to see. Hopefully this time around they'll receive listing approval. Many redactions' and it's a preliminary prospectus. Please post any updates as the approval process moves along.
agordon, how recent is the Edding document? Please post the link. The last time I searched for an updated prospectus I found something from 2021, IRRC. Until they get another infusion of equity they have limited funds but the financials were outdated so unless they get approval for their IPO to be listed on the Hong Kong exch. Amarin shouldn't expect anything of substance re the revs.
LBL, Please help the loyal amarinians and send a post if there's anything on your end that could enlighten us about the situation with AD and Sarissa. Maybe his personal life is overwhelming him. He appointed Patrice Bonfiglio as the new President of Sarissa. She's also on the board of Amarin. Any thoughts there??? Thanks
denisk, the incorrect info was filed in the proxy re the voting options, please see the asterisk listed in the link below. Resolution 5*
https://www.sec.gov/Archives/edgar/data/897448/000119312523163069/d455942ddefa14a.htm
capt, thanks for that information. So it appears that we might start seeing an uptick in revenues?? Yeah!
Monk44, I will try but I haven't been in the ihub loop for a few months. Actually I'm perplexed about the current situation with amarin. It seems they screwed up with wording when they filed their proxy last month.
Sleven, I found this post while searching for info on EddingPharm. You may want to read in its entirety.
lettruthringout
Re: north40000 post# 365314
Tuesday, January 04, 2022 4:38:05 PM
Post#
365325
of 410498
Not all roses for Edding
Eton Pharmaceutical’s Hong Kong Stocks "Three Enters the Palace"
January 02, 2022 18:08:23
Meowz0, I miss your nutty jargon. Lol
I'm wondering if anyone read the cover sheet from the proxy statement. It clearly states the company is behind on every front. It will take time for a turn around to happen. No offense taken re Jersey right now it smells like one huge fireplace burning.
Apologies if this tweet is old news.
My thoughts on our publication demonstrating improvement in coronary physiology with icosapent ethyl using #FFRCT. Our study is the first to suggest #FFRCT can be a way to assess the effect of cardiovascular drugs. @DLBHATTMD @BudoffMd @CardiologyToday #YesCCT @Heart_SCCT https://t.co/iCDQhMuijy
— Mark Rabbat MD (@MGRabbatMD) June 2, 2023
Tatsumi, thank for follow up. Been there done that. Good ole amrn
Sleven, I didn't create that narrative I have read articles stating such. Dont ask me to post a link I've put amarin on the back burner moved on till the stock gives me a reason to participate in on going dialogue for no return on my time.
Sleven, wonder where Eddingham found the funding to pay amarin with no IPO?
Tatsum, if I understand your post about where the drug is manufactured and if it's out of their domain they get annoyed if they can't control the source. IIRC Mochida will be the supplier China has no source as far as I know.
Maybe we'll get some additional info when they start selling. next we need germany but they're in a recession now so hurry up and wait.
Sleven why do u say that?
Invest83838, Amen to the miracle that I never thought would occur. If it wasn't for the Sarissa crew taking over Amarin guaranteed it would never have happened. I wonder what the next step will be for distribution and sales. It's all about connections and who you know!!!
Another patent win for a branded product vs generic infringer Norwich Pharma. Maybe Amarin has a chance for a win after all????
https://ir.bauschhealth.com/news-releases/2023/05-17-2023a
birdrock, thanks for the link. Interesting to see how many prime brokers they have, MS, Northern Trust, GSCO, MLPFS, Stifel Nicolaus & Citibank.
skipperdog, thanks for pointing that out. It's nonstop with the assumption that Sarissa has sold shs without filing. Retail mentality has a hard time wrapping their heads around the "other" side of the street which is difficult to understand unless you've lived it.
hayward, Morgan Stanley is probably one of Sarissa's prime brokers. The amrn shs are probably held in street name at MS. I'm assuming Sarrisa uses a few prime brokers to hold the shs in their portfolio to spread the risk. See the link below which explains the function of a prime broker.
They haven't sold any shs no 13D filing no sale.
https://comparebrokers.co/compare/prime-brokers/
Hey DTG, looky, looky. They are finally subletting the majority of space in Bridgewater. We have 16K sq ft remaining. Now that's more like it!!!
Also, inventory numbers have come down, at a cost but it's better than giving it away.
below is an excerpt from the 10Q.
Lessor
The Company classifies contractual lease arrangements entered as a lessor as a sales-type, direct financing or operating lease as described in ASC 842. For sales-type leases, the Company derecognizes the leased asset and recognizes the lease investment on the balance sheet.
Sleven, I thought he would be in the room maybe to introduce himself??? Guess not. My take about the cc is pretty much bland with no definitive direction but Berg has only been on the job for 2 wks so got to give him some slack. We did have 400,000 in revs from the UK. It's a start???
CBB, agreed. Something is going on... the volume is telling us something. Let's see what Arron Berg has to say. Our new COB will speak as well it should be interesting.
CBB, been off the grid for a while but still check in. The volume and a few big blocks traded especially the one at the close was over a 500,000 sh buy order.
Maybe we'll get some promising news tomorrow on the cc.
Maybe they'll start giving some future guidance as well????
Thanks. Just another thing I have to learn how to use...lol
Raf, thanks for the link I'm not on spotify but the 15 mins of the interview are worth listening to, it reminds me of what Vascepa has gone through with the nay-sayers over the years. It's similar to the Nissen's and AF's thinking about vascepa, it's only fish oil and MO is not a good placebo. It makes you wonder who's getting paid to trash the Reduce-it trial.
gozips, yup, that makes sense. I wonder if they can mutually agree to walk away after 8 years of nothing? I wonder who will speak on the conf call? Maybe Odysseas? Too soon for Aaron Berg to speak. I would love to hear from AD even if it's just to introduce himself.
gozips, first we have to find a partner in China. Eddingpharma ain't happening. I'm eager to read the 1stQ filing to see what's changed or mentioned who we are partners with and which companies are not mentioned.
this is from the same Mochida pharma business overview as from my previous post.
MND-21 ethyl icosapentate Phase ? Hypertriglyceridemia Oral Collaboration with Sumitomo Pharmaceuticals (Suzhou)<China>
dogn, this only mentions amarin under collaborations. Nothing on vascepa.
https://www.mochida.co.jp/english/business/licensing.html
someone bought 530,000 shs @1.405 about 15 minutes ago? Interesting maybe we have a new CEO???
jasbg, thanks for the youtube post. It has confirmed what I've known for years. I mainly stick with a Mediterranean diet more so as I get older and joined weight watchers to keep me honest with my weight. Had a blood test the other day, and my cholesterol has dropped 30 points!
raf, I couldn't find him on twitter, do you know his handle? Thx
I hope that guy is real.
Michael, yeah me too. Let the games begin. Again.
Nuke, NV yes Nevada. Gee whizz kowa hasn't generated a dime wonder what happened there. All the idiotic meaningless agreements make no sense.
nuke, thanks. Who the hell is Kowa?? LOL, has anyone heard their name recently???
So if Amarin has always been a DE corp. How did we get to NV? Damn mystery!
The recent filing in 2020 mentions the lawsuit being filed in DE. I haven't been following this case since we've all others.
https://www.globenewswire.com/news-release/2020/12/01/2137000/0/en/Amarin-Files-Patent-Infringement-Lawsuit-Against-Hikma.html
nuke, I'm curious about this deal with Amarin Inc. being a DE corp. It never existed till this recent KM filing. Something is weird.
Either the lawyers found a social security ID for the company or they're stupid. Boy oh boy would that change everything.
I googled Amarin Inc. of DE nothing came up. It's never mentioned in any of their filings either.